MANAGEMENT AND RESEARCH IN DENTAL PRACTICE DURING THE COVID-19 PANDEMICAN OVERVIEW
A pandemic is defined as “an epidemic occurring worldwide, or over a very wide area, crossing international boundaries and usually affecting a large number of people”.1 In the early December 2019, people in Wuhan province of China reported with anatypical respiratory disease, which rapidly spread to other provinces. The virus was then named as the severe Acute respiratory syndrome corona virus-2 (SARS-CoV2), since it had a very high homology to the initial SARS CoV in 2002.2 Though it was initially considered to have a zoonotic infection associated from a seafood market in Wuhan province, it was later discovered that the common mode of transmission was human to human leading to a major outbreak. The disease caused by this virus was named as Corona virus disease and was declared as a pandemic by the World Health Organisation (WHO). As of August 2020, more than 22 lakh cases were reported worldwide according to the Center for Systems Science and Engineering (CSSE) at John Hopkins University (JHUoMCr). There has been an exponentially increasing number of patients reported with severe disease who have continued to succumb worldwide. Epidemiological studies show that mortalities are higher in elder population3 and the incidence is much lower in children.4–6 Current medical management is largely supportive with no targeted therapy available. Several drugs including lopinavirritonavir, remdesivir, hydroxychloroquine, and azithromycin are being tested in clinical trials7,8 but none of them have been proven to be a therapeutic. More therapies are being tested in clinical trials. In a phased manner which has now reached a stage of human trial in certain countries. A large number of countries have implemented social distancing and lockdown to mitigate further spread of the virus. This article will give a brief description of the corona virus and it implications in dentistry and dental research.